It certainly is the quarter to get excited...
OTAT feedback will enable
- The company to re-apply for GvHD approval
- The company to initiate the all cause ARDS / or 2nd Covid phase 3 trial
- Accelerate the closing of the Novartis deal and milestone payments if the feedback enables 1 or 2
FDA feedback on the final CLBP trial
1. Should enable approval for the final joint EU/FDA trial , and associated Grunenthal milestone payments
FDA feedback on the block buster Dream HF trial
1. Enables the company to continue with it's plan of a second phase 3, or possibly other avenues as directed from the FDA
AHA and NEJM article release
1. I suspect this is really going to turn some heads as the world comes to grips with the only treatment that has proven so far to halt class 2 CHF progression in it's tracks. Big money are going to come wanting a slice of the pie and may end with an agreement earlier than people think or realize. IMO this agreement is going to be much bigger than the Novartis deal.
2. I think this may well be the kick starter for Tasly's CHF studies in China since the results are so completely astounding. Remember the Tasly deal...
Mesoblast will receive double-digit escalating royaltieson net product sales in China. Mesoblast is eligible to receive six escalating milestone payments upon the product candidates reaching certain sales thresholds in China.
- Forums
- ASX - By Stock
- the shorts will bail with margin calling and announcements due
It certainly is the quarter to get excited...OTAT feedback will...
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B |
Open | High | Low | Value | Volume |
$1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 26808 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 16001 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 26808 | 1.440 |
2 | 28628 | 1.435 |
8 | 68533 | 1.430 |
5 | 155422 | 1.425 |
4 | 32112 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.445 | 16001 | 1 |
1.450 | 4515 | 1 |
1.455 | 6500 | 1 |
1.460 | 45215 | 3 |
1.465 | 36008 | 2 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online